This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
Clinical trial NCT06536023 · COMPLETED
Trial details
- NCT number
- NCT06536023
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2025-07-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.